Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2526)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5696)
  2. Department of Medicine (5686)
  3. GSK Faculty (1659)
  4. Human Oncology and Pathogenesis Program (1158)
  5. Department of Pathology and Laboratory Medicine (1130)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (786)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (204)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (690)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5696)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer
    Journal Article

    Grisham, R. N.; Iyer, G.; Sala, E.; Zhou, Q.; Iasonos, A.; DeLair, D.; Hyman, D. M.; Aghajanian, C.
    International Journal of Gynecological Cancer (2014)

    Fulltext@MSK | Save
  • Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors
    Journal Article

    Feldman, D. R.; Iyer, G.; Van Alstine, L.; Patil, S.; Al-Ahmadie, H.; Reuter, V. E.; Bosl, G. J.; Chaganti, R. S.; Solit, D. B.
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Cardiovascular events among 1090 cancer patients treated with sunitinib, interferon, or placebo: A comprehensive adjudicated database analysis demonstrating clinically meaningful reversibility of cardiac events
    Journal Article

    Ewer, M. S.; Suter, T. M.; Lenihan, D. J.; Niculescu, L.; Breazna, A.; Demetri, G. D.; Motzer, R. J.
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Sorbitol as a novel mechanism of hypoxia-inducible factor (HIF) pathway activation in clear cell papillary renal cell carcinoma (CCPRCC)
    Meeting Abstract

    Tickoo, S. K.; Hakimi, A. A.; Xu, J.; Lee, C. H.; Chen, Y. B.; Stirdivant, S.; Neri, B.; Wolfert, R.; Fine, S. W.; Al-Ahmadie, H.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Fibroblastic variant of endometrial stromal sarcoma - Genetic reclassification
    Meeting Abstract

    Reyes, C.; Bennett, J.; Rouzbahman, M.; Melnyk, N.; Huntsman, D. G.; Nucci, M. R.; Oliva, E.; Soslow, R. A.; Lee, C. H.
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: Results of CALGB 90202 (alliance)
    Journal Article

    Smith, M. R.; Halabi, S.; Ryan, C. J.; Hussain, A.; Vogelzang, N.; Stadler, W.; Hauke, R. J.; Monk, J. P.; Saylor, P.; Bhoopalam, N.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma
    Journal Article

    Hutson, T. E.; Escudier, B.; Esteban, E.; Bjarnason, G. A.; Lim, H. Y.; Pittman, K. B.; Senico, P.; Niethammer, A.; Lu, D. R.; Hariharan, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Androgen dynamics and serum PSA in patients treated with abiraterone acetate
    Journal Article

    Ryan, C. J.; Peng, W.; Kheoh, T.; Welkowsky, E.; Haqq, C. M.; Chandler, D. W.; Scher, H. I.; Molina, A.
    Prostate Cancer and Prostatic Diseases (2014)

    Fulltext@MSK | Save
  • Assessment of progression-free survival as a surrogate end-point for overall survival in patients with metastatic renal cell carcinoma
    Journal Article

    NeĢgrier, S.; Bushmakin, A. G.; Cappelleri, J. C.; Korytowsky, B.; Sandin, R.; Charbonneau, C.; Michaelson, M. D.; Figlin, R. A.; Motzer, R. J.
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial
    Journal Article

    Kwon, E. D.; Drake, C. G.; Scher, H. I.; Fizazi, K.; Bossi, A.; Van Den Eertwegh, A. J. M.; Krainer, M.; Houede, N.; Santos, R.; Mahammedi, H.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save